BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9094859)

  • 1. Hepatitis B and C infection among drug abusers in Nepal.
    Shrestha SM; Shrestha DM; Gafney TE; Maharjan KG; Tsuda F; Okamoto H
    Trop Gastroenterol; 1996; 17(4):212-3. PubMed ID: 9094859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
    Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
    J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal.
    Shrestha SM; Tsuda F; Okamoto H; Tokita H; Horikita M; Tanaka T; Miyakawa Y; Mayumi M
    Hepatology; 1994 Apr; 19(4):805-9. PubMed ID: 8138250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serological investigation on intrafamilial transmission of HCV infection].
    Wang S; Huang Y; Yu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Feb; 15(1):34-7. PubMed ID: 7521795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibody prevalence for hepatitis C and other parenterally transmissible viral diseases in i. v. drug dependent patients].
    Neuwald C; Pont J; Tomasits J; Bauer K
    Acta Med Austriaca; 1992; 19(2):47-8. PubMed ID: 1324551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of markers of infection with hepatitis B and C viruses in immigrants of operation Solomon, 1991.
    Flatau E; Segol O; Shneour A; Tabenkin H; Raz R
    Isr J Med Sci; 1993; 29(6-7):387-9. PubMed ID: 8394300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia.
    Njoh J
    East Afr Med J; 1995 Aug; 72(8):490-1. PubMed ID: 7588140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infections in oral and injectable drug users.
    Woodfield DG; Harness M; Rix-Trott K
    N Z Med J; 1993 Aug; 106(961):332-4. PubMed ID: 8341473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection].
    Cheng H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.
    Jilg W; Sieger E; Zachoval R; Schätzl H
    J Hepatol; 1995 Jul; 23(1):14-20. PubMed ID: 8530804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitis.
    De Mercato R; Ciampi R; Romano A; Guarnaccia D; Siciliano V; Cantiello JP; Rippa O; Celentano U; Selva V; Romano C
    Boll Soc Ital Biol Sper; 1990 Sep; 66(9):841-7. PubMed ID: 2127365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of virus-induced damage markers in the diagnosis of viral hepatitis].
    Randone A; Oliveri F; Piantino P; Colombatto P; Verme G; Bonino F; Brunetto MR
    Minerva Gastroenterol Dietol; 1995 Dec; 41(4):261-3. PubMed ID: 8664411
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria].
    Ayed Z; Houinato D; Hocine M; Ranger-Rogez S; Denis F
    Bull Soc Pathol Exot; 1995 Apr; 88(5):225-8. PubMed ID: 8646011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.
    Inokuchi K; Nakata K; Hamasaki K; Daikoku M; Nakao K; Kato Y; Yatsuhashi H; Koga M; Yano M; Nagataki S
    J Hepatol; 1996 Mar; 24(3):258-64. PubMed ID: 8778190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBV, HCV and HIV infections among drug addicts-residents of rehabilitation and social adjustment centers in the Gdańsk district].
    Smiatacz T; Własiuk M; Paszkiewicz J; Zielińska W
    Przegl Epidemiol; 1991; 45(4):351-5. PubMed ID: 1841415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of antibody to hepatitis C virus in 177 drug addicts].
    Ye S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):45-8. PubMed ID: 8389248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts].
    Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F
    Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determinants of the prevalence of hepatitis B viral infection in parenteral drug abusers].
    Torrella Ramos A; Hernández Aguado I; Santos Rubio C; Fernández García E; García de la Hera M; Aviñó Rico MJ
    Rev Clin Esp; 1993 Dec; 193(9):475-9. PubMed ID: 8108578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B and C infection in alcoholics].
    Boroń-Kaczmarska A; Kozłowska H; Sidun Z
    Przegl Epidemiol; 1994; 48(1-2):17-20. PubMed ID: 8073136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.